Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease

Calcified aortic valve disease (CAVD) is the most common valvular cardiovascular disease with increasing incidence and mortality. The primary treatment for CAVD is surgical or transcatheter aortic valve replacement and there remains a lack of effective drug treatment. Recently, lipoprotein (a) (Lp(a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiahui, Lei, Hao, Liu, Leiling, Xu, Danyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830536/
https://www.ncbi.nlm.nih.gov/pubmed/35155427
http://dx.doi.org/10.3389/fcell.2022.812368

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830536/
https://www.ncbi.nlm.nih.gov/pubmed/35155427
http://dx.doi.org/10.3389/fcell.2022.812368

Ejemplares similares